尿液微生物组与代谢组可区分膀胱过度活动症与生理状态,并反映近期抗生素使用与治疗反应
OAB患者尿中Escherichia、Enterococcus和Proteus富集,而无OAB者Megasphaera和Scardovia更丰富;菌群组成还随OAB表型、糖尿病状态、近期抗生素暴露及治疗反应而异。
要点
- OAB患者尿液富集Escherichia、Enterococcus和Proteus等菌属。
- 无OAB者尿中Megasphaera和Scardovia相对丰度更高。
- 菌群差异与糖尿病、近期抗生素使用及OAB治疗反应相关。
核心结论
- 尿液微生物组与代谢组可区分OAB与生理状态,并与患者特征及治疗反应相关。
研究设计与样本
- 从无泌尿系统诊断的女性和OAB女性尿液中提取DNA与代谢物,行16S rRNA测序和非靶向代谢组学分析。
主要发现
- 无泌尿系统疾病者中最丰富的门为Bacilliota,最丰富的属为Lactobacillus、Escherichia和Prevotella。
- Megasphaera和Scardovia在无OAB者中比OAB者更丰富(各:log2倍变化[FC] -3.7,P < .001)。
- Escherichia(log2-FC 5.9)、Enterococcus(log2-FC 3.5)和Proteus(log2-FC 3.1)在OAB患者尿中显著更丰富(P < .001)。
- 有无OAB者间及按糖尿病状态分组的β多样性存在差异(P < .05)。
- 细菌属相对丰度随OAB表型、糖尿病状态、近期抗生素暴露及OAB治疗反应而异(P < .05)。
临床怎么用
- 结果提示可探索微生物调节策略以增强现有OAB治疗,但尚需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To characterize and compare the bacterial urinary microbiome in individuals with and without overactive bladder (OAB), and secondarily compare its composition by phenotype, comorbidities, recent antibiotic exposure, and therapeutic response. MATERIALS AND METHODS: We isolated DNA and metabolites from the urine of women without urologic diagnoses and with OAB. Bacterial profiles were generated with 16S rRNA sequencing, and metabolite profiles were generated with untargeted metabolomics. Alpha-diversity and beta-diversity, relative abundance, and microbe-metabolite co-occurrence interaction networks were identified by OAB status and patient characteristics. RESULTS: One hundred fifty-two participants were included, and bacteria were identified in all urine samples. Bacilliota was the most abundant phylum and Lactobacillus, Escherichia, and Prevotella the most abundant genera in individuals without urologic conditions. Megasphaera and Scardovia were the primary genera more abundant in individuals without OAB than those with OAB (each: log2-fold change [FC] -3.7 P < .001). Escherichia (log2-FC 5.9), Enterococcus (log2-FC 3.5), and Proteus (log2-FC 3.1) were the primary genera significantly more abundant in the urine of individuals with OAB than those without (P < .001). Beta diversity differed between individuals with and without OAB and by diabetes mellitus status (P < .05). Relative abundance of bacterial genera differed by OAB phenotype, diabetes mellitus status, recent antibiotic exposure, and response to OAB treatment (P < .05). Microbe-metabolite interaction networks demonstrated central microbes and metabolites in the healthy and OAB states. CONCLUSIONS: The study provides new understanding regarding the physiological bacterial composition of urine, and that in the context of OAB. Furthermore, microbiota differed by patient phenotype, comorbidities, recent antibiotic exposure, and therapeutic response. The results inform strategies of microbiological modulation to augment existing therapeutic strategies.
引用
- Werneburg GT, Gross MD, Hettel DR, et al. Urinary Microbiome and Metabolome Differentiate Overactive Bladder From the Physiological State, and Reflect Recent Antibiotic Use and Treatment Response. J Urol. 2026. PMID: 41666295. doi:10.1097/JU.0000000000004990
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。